What is colorectal cancer?

Colorectal cancer is a type of cancer that starts in the colon or rectum. It is one of the most common types of cancer and can be influenced by factors like diet and genetics.

What is a subsidiary?

A subsidiary is a company that is completely or partially owned and controlled by another company, known as the parent company.

Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Headlines > China's Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche

Headlines

China's Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche

Published by Global Banking & Finance Review®

Posted on October 16, 2025

1 min read

Last updated: January 21, 2026

China's Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche - Headlines news and analysis from Global Banking & Finance Review

China's Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche

Quick Summary

Hansoh Pharma Enters $1.45 Billion Licensing Deal with Roche for Cancer Drug

Overview of the Licensing Agreement

Details of the Agreement

Key Takeaways

Frequently Asked Questions about China's Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche